{"transactions":[{"id":1479139,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T22:00:09.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":28763,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-016995","document":"form4-06142024_060606.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924016995/form4-06142024_060606.xml","form_type":"4"}},{"id":1479138,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-06-14T22:00:09.000Z","date":"2024-06-14","kind":"sale","planned":true,"acquired":false,"shares":15000,"price":25.03,"value":375450.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":5022,"source":{"system":"sec-edgar","filing":"0001415889-24-016995","document":"form4-06142024_060606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924016995/form4-06142024_060606.xml","form_type":"4"}},{"id":1479137,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-06-14T22:00:09.000Z","date":"2024-06-14","kind":"exercise","planned":true,"acquired":true,"shares":15000,"price":2.14,"value":32100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,062 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on April 30, 2024 in a transaction that is exempt under Rule 16b-3(c) and 16b3(d)."}],"balance_after":20022,"source":{"system":"sec-edgar","filing":"0001415889-24-016995","document":"form4-06142024_060606.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924016995/form4-06142024_060606.xml","form_type":"4"}},{"id":1542605,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-12T22:00:08.000Z","date":"2024-04-10","kind":"exercise","planned":true,"acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":43763,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001415889-24-010773","document":"form4-04122024_060401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010773/form4-04122024_060401.xml","form_type":"4"}},{"id":1542604,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-12T22:00:08.000Z","date":"2024-04-10","kind":"sale","planned":true,"acquired":false,"shares":771,"price":27.5646,"value":21252.3066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $27.35 to $27.74, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-24-010773","document":"form4-04122024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010773/form4-04122024_060401.xml","form_type":"4"}},{"id":1542603,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-12T22:00:08.000Z","date":"2024-04-10","kind":"sale","planned":true,"acquired":false,"shares":6729,"price":26.7706,"value":180139.3674,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.32 to $27.315, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2731,"source":{"system":"sec-edgar","filing":"0001415889-24-010773","document":"form4-04122024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010773/form4-04122024_060401.xml","form_type":"4"}},{"id":1542602,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-12T22:00:08.000Z","date":"2024-04-10","kind":"exercise","planned":true,"acquired":true,"shares":7500,"price":2.14,"value":16050.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":9460,"source":{"system":"sec-edgar","filing":"0001415889-24-010773","document":"form4-04122024_060401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010773/form4-04122024_060401.xml","form_type":"4"}},{"id":1549898,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-04-03T22:00:15.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":false,"shares":12495,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":15768,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":12495},"source":{"system":"sec-edgar","filing":"0001415889-24-010136","document":"form4-04032024_060404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010136/form4-04032024_060404.xml","form_type":"4"}},{"id":1549897,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:15.000Z","date":"2024-04-01","kind":"sale","planned":true,"acquired":false,"shares":12495,"price":31.2291,"value":390207.6045,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.00 to $31.75, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-24-010136","document":"form4-04032024_060404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010136/form4-04032024_060404.xml","form_type":"4"}},{"id":1549896,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-04-03T22:00:15.000Z","date":"2024-04-01","kind":"exercise","planned":true,"acquired":true,"shares":12495,"price":2.14,"value":26739.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":14455,"source":{"system":"sec-edgar","filing":"0001415889-24-010136","document":"form4-04032024_060404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924010136/form4-04032024_060404.xml","form_type":"4"}},{"id":1576853,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-14T22:00:17.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":false,"shares":2016,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":51263,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":2016},"source":{"system":"sec-edgar","filing":"0001415889-24-008033","document":"form4-03142024_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008033/form4-03142024_060304.xml","form_type":"4"}},{"id":1576852,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-14T22:00:17.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":false,"shares":2051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":53279,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":2051},"source":{"system":"sec-edgar","filing":"0001415889-24-008033","document":"form4-03142024_060304.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008033/form4-03142024_060304.xml","form_type":"4"}},{"id":1576851,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-14T22:00:17.000Z","date":"2024-03-13","kind":"sale","planned":true,"acquired":false,"shares":2016,"price":25.0223,"value":50444.9568,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.08, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-24-008033","document":"form4-03142024_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008033/form4-03142024_060304.xml","form_type":"4"}},{"id":1576850,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-14T22:00:17.000Z","date":"2024-03-13","kind":"exercise","planned":true,"acquired":true,"shares":2016,"price":2.14,"value":4314.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":3976,"source":{"system":"sec-edgar","filing":"0001415889-24-008033","document":"form4-03142024_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008033/form4-03142024_060304.xml","form_type":"4"}},{"id":1576849,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-14T22:00:17.000Z","date":"2024-03-12","kind":"sale","planned":true,"acquired":false,"shares":2051,"price":25.0461,"value":51369.5511,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.19, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-24-008033","document":"form4-03142024_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008033/form4-03142024_060304.xml","form_type":"4"}},{"id":1576848,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-14T22:00:17.000Z","date":"2024-03-12","kind":"exercise","planned":true,"acquired":true,"shares":2051,"price":2.14,"value":4389.14,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":4011,"source":{"system":"sec-edgar","filing":"0001415889-24-008033","document":"form4-03142024_060304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924008033/form4-03142024_060304.xml","form_type":"4"}},{"id":1584332,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":false,"shares":3433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":55330,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":3433},"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584331,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-08","kind":"exercise","planned":true,"acquired":false,"shares":114,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":58763,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":114},"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584330,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":false,"shares":20986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":58877,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":20986},"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584329,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":false,"shares":1400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":28263,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1400},"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584328,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":10,"price":26.305,"value":263.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584327,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-11","kind":"sale","planned":true,"acquired":false,"shares":3423,"price":25.2423,"value":86404.3929,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.88, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1970,"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584326,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-11","kind":"exercise","planned":true,"acquired":true,"shares":3433,"price":2.14,"value":7346.62,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":5393,"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584325,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-08","kind":"sale","planned":true,"acquired":false,"shares":114,"price":25,"value":2850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584324,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-08","kind":"exercise","planned":true,"acquired":true,"shares":114,"price":2.14,"value":243.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":2074,"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584323,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-07","kind":"sale","planned":true,"acquired":false,"shares":22386,"price":25.0017,"value":559688.0562,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.289, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1584322,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2024-03-11T22:00:20.000Z","date":"2024-03-07","kind":"exercise","planned":true,"acquired":true,"shares":22386,"price":2.14,"value":47906.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2023."}],"balance_after":24346,"source":{"system":"sec-edgar","filing":"0001415889-24-007534","document":"form4-03112024_060307.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924007534/form4-03112024_060307.xml","form_type":"4"}},{"id":1672143,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-01-24T23:00:12.000Z","date":"2024-01-22","kind":"grant","planned":false,"acquired":true,"shares":66586,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on February 22, 2024."}],"balance_after":66586,"derivative":{"exercise_price":20,"expiration_date":"2034-01-21","underlying":"Common Stock","underlying_shares":66586},"source":{"system":"sec-edgar","filing":"0001415889-24-001772","document":"form4-01242024_060102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588924001772/form4-01242024_060102.xml","form_type":"4"}},{"id":2026598,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-08T23:10:19.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on March 7, 2023."}],"balance_after":85000,"derivative":{"exercise_price":25.57,"expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001415889-23-002173","document":"form4-02082023_060206.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588923002173/form4-02082023_060206.xml","form_type":"4"}},{"id":2088092,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":2906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":79863,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":2906},"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2088091,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":7094,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":29663,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":7094},"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2088090,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-09","kind":"exercise","acquired":false,"shares":3969,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":36757,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":3969},"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2088089,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-12","kind":"sale","acquired":false,"shares":10000,"price":30.0428,"value":300428.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.00 to $30.39, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2088088,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":10000,"price":2.14,"value":21400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":11960,"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2088087,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-09","kind":"sale","acquired":false,"shares":583,"price":25.2327,"value":14710.6641,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.01 to $25.41, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2088086,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-09","kind":"sale","acquired":false,"shares":3386,"price":24.2335,"value":82054.631,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $25.00, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2543,"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2088085,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-13T23:00:12.000Z","date":"2022-12-09","kind":"exercise","acquired":true,"shares":3969,"price":2.14,"value":8493.66,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":5929,"source":{"system":"sec-edgar","filing":"0001415889-22-012508","document":"form4-12132022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012508/form4-12132022_061201.xml","form_type":"4"}},{"id":2091218,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-08","kind":"exercise","acquired":false,"shares":10124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"A total of 50,850 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on March 22, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":40726,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":10124},"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091217,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-08","kind":"exercise","acquired":false,"shares":1887,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":82769,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1887},"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091216,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-07","kind":"exercise","acquired":false,"shares":11637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 98,676 shares subject to an employee stock option were granted on April 2, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":84656,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":11637},"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091215,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-08","kind":"sale","acquired":false,"shares":11031,"price":24.2022,"value":266974.4682,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $24.00 to $24.50, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091214,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-08","kind":"sale","acquired":false,"shares":20,"price":20.58,"value":411.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":12991,"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091213,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-08","kind":"sale","acquired":false,"shares":960,"price":20.1185,"value":19313.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.575 to $20.54, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":13011,"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091212,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-08","kind":"exercise","acquired":true,"shares":12011,"price":2.14,"value":25703.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":13971,"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091211,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-07","kind":"sale","acquired":false,"shares":4558,"price":20.4021,"value":92992.7718,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.02 to $20.56, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091210,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-07","kind":"sale","acquired":false,"shares":7079,"price":19.3657,"value":137089.7903,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.97, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":6518,"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2091209,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-09T23:00:25.000Z","date":"2022-12-07","kind":"exercise","acquired":true,"shares":11637,"price":2.14,"value":24903.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":13597,"source":{"system":"sec-edgar","filing":"0001415889-22-012355","document":"form4-12092022_061201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922012355/form4-12092022_061201.xml","form_type":"4"}},{"id":2098454,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-03T00:00:11.000Z","date":"2022-11-30","kind":"exercise","acquired":false,"shares":85,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":96293,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":85},"source":{"system":"sec-edgar","filing":"0001415889-22-011982","document":"form4-12022022_071201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011982/form4-12022022_071201.xml","form_type":"4"}},{"id":2098453,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-03T00:00:11.000Z","date":"2022-11-30","kind":"sale","acquired":false,"shares":85,"price":19.0604,"value":1620.134,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.17, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-011982","document":"form4-12022022_071201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011982/form4-12022022_071201.xml","form_type":"4"}},{"id":2098452,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-12-03T00:00:11.000Z","date":"2022-11-30","kind":"exercise","acquired":true,"shares":85,"price":2.14,"value":181.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":2045,"source":{"system":"sec-edgar","filing":"0001415889-22-011982","document":"form4-12022022_071201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011982/form4-12022022_071201.xml","form_type":"4"}},{"id":2103449,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-28T22:00:23.000Z","date":"2022-11-23","kind":"exercise","acquired":false,"shares":1261,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":96378,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":1261},"source":{"system":"sec-edgar","filing":"0001415889-22-011794","document":"form4-11282022_051101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011794/form4-11282022_051101.xml","form_type":"4"}},{"id":2103448,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-28T22:00:23.000Z","date":"2022-11-23","kind":"sale","acquired":false,"shares":1261,"price":19.0708,"value":24048.2788,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.40, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-011794","document":"form4-11282022_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011794/form4-11282022_051101.xml","form_type":"4"}},{"id":2103447,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-28T22:00:23.000Z","date":"2022-11-23","kind":"exercise","acquired":true,"shares":1261,"price":2.14,"value":2698.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":3221,"source":{"system":"sec-edgar","filing":"0001415889-22-011794","document":"form4-11282022_051101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011794/form4-11282022_051101.xml","form_type":"4"}},{"id":2107022,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-22","kind":"exercise","acquired":false,"shares":174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":97639,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":174},"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107021,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-21","kind":"exercise","acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":97813,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":2},"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107020,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":861,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"A total of 98,676 shares subject to an employee stock option were granted on April 1, 2021, with 25% of this option vested on June 4, 2022, and the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":97815,"derivative":{"exercise_price":2.14,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":861},"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107019,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-22","kind":"sale","acquired":false,"shares":174,"price":19.0121,"value":3308.1054,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.03, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107018,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-22","kind":"exercise","acquired":true,"shares":174,"price":2.14,"value":372.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":2134,"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107017,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-21","kind":"sale","acquired":false,"shares":2,"price":19,"value":38.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107016,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-21","kind":"exercise","acquired":true,"shares":2,"price":2.14,"value":4.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."}],"balance_after":1962,"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107015,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":81,"price":20.1335,"value":1630.8135,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.095 to $20.29, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":1960,"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107014,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":780,"price":19.4541,"value":15174.198,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.06 to $20.045, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request."}],"balance_after":2041,"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2107013,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-11-23T01:00:11.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":861,"price":2.14,"value":1842.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 15, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,960 shares purchased under the Issuer's 2021 Employee Stock Purchase Plan on October 31, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d)."}],"balance_after":2821,"source":{"system":"sec-edgar","filing":"0001415889-22-011708","document":"form4-11222022_081101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000141588922011708/form4-11222022_081101.xml","form_type":"4"}},{"id":2470014,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-12-16T23:00:12.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":65433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable in 48 substantially equal monthly installments, with the first installment vesting on January 14, 2022."}],"balance_after":65433,"derivative":{"exercise_price":10.61,"expiration_date":"2031-12-13","underlying":"Common Stock","underlying_shares":65433},"source":{"system":"sec-edgar","filing":"0001493152-21-031752","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000149315221031752/ownership.xml","form_type":"4"}},{"id":2647897,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T22:29:43.000Z","date":"2021-06-29","kind":"grant","acquired":true,"shares":76900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of this option shall vest and become exercisable on June 29, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."}],"balance_after":76900,"derivative":{"exercise_price":14,"expiration_date":"2031-06-28","underlying":"Common Stock","underlying_shares":76900},"source":{"system":"sec-edgar","filing":"0001104659-21-088375","document":"tm2121189-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921088375/tm2121189-2_4seq1.xml","form_type":"4"}},{"id":2647896,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T22:29:43.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":98676,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of this option shall vest and become exercisable on June 4, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":98676,"derivative":{"exercise_price":2.144,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":98676},"source":{"system":"sec-edgar","filing":"0001104659-21-088375","document":"tm2121189-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921088375/tm2121189-2_4seq1.xml","form_type":"4"}},{"id":2647895,"issuer":{"id":4757,"kind":"organization","name":"Jade Biosciences, Inc."},"owners":[{"id":89879,"kind":"person","name":"Eldridge George A","position":1,"cik":"0001413006","reported_name":"Eldridge George A","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-01T22:29:43.000Z","date":"2021-04-02","kind":"grant","acquired":true,"shares":50850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"kind","element":"transactionCoding","label":"F2","text":"This transaction occurred prior to the Issuer's initial public offering, and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3."},{"field":"shares","element":"transactionShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of this option shall vest and become exercisable on March 22, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"On June 22, 2021, the Issuer completed a one-for-3.1060103 reverse stock split of the Issuer's Common Stock (the \"Reverse Split\"). This amount has been adjusted to give effect to the Reverse Split."}],"balance_after":50850,"derivative":{"exercise_price":2.144,"expiration_date":"2031-04-01","underlying":"Common Stock","underlying_shares":50850},"source":{"system":"sec-edgar","filing":"0001104659-21-088375","document":"tm2121189-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921088375/tm2121189-2_4seq1.xml","form_type":"4"}}]}